Insmed Incorporated - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
INSM Nasdaq 2830 www.insmed.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Insmed Incorporated

INSM Stock Jumps on 2025 Preliminary Sales, 2026 Goals Announced - Jan 12th, 2026 7:32 am
Is It Too Late To Reassess Insmed (INSM) After Its Huge Share Price Surge? - Jan 10th, 2026 8:13 pm
The Bull Case For Insmed (INSM) Could Change Following Bold 2025 Revenue Guidance Hike - Learn Why - Jan 10th, 2026 4:12 pm
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026 - Jan 9th, 2026 9:19 am
Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference - Jan 9th, 2026 5:00 am
Insmed’s ‘ginormous’ lung drug sales; J&J’s US pricing deal - Jan 9th, 2026 4:28 am
Jim Cramer on Insmed: “This One Is Worth Keeping an Eye On” - Jan 8th, 2026 5:20 am
What Catalysts Are Quietly Shifting The Narrative For Insmed (INSM)? - Jan 6th, 2026 4:15 pm
Stock Market Today, Jan. 6: Alumis Shares Surge on Positive Phase 3 Psoriasis Data for Envudeucitinib - Jan 6th, 2026 3:32 pm
INSM Stock Up 78% in 6 Months: Here's What You Need to Know - Jan 2nd, 2026 6:15 am
Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference - Jan 2nd, 2026 5:00 am
Ultragenyx (RARE) Moves 15.5% Higher: Will This Strength Last? - Dec 31st, 2025 7:01 am
The Zacks Analyst Blog Mineralys, Lyell, Insmed and Nektar - Dec 26th, 2025 12:33 am
4 Drug, Biotech Stocks Rising More Than 50% in 2025 With Room to Grow - Dec 24th, 2025 8:51 am
US Stock Market Today: S&P 500 Futures Rise amid Global Rate Hikes, Cooling Inflation - Dec 19th, 2025 3:07 am
The 'Worst-Case Scenario' — Why Insmed Just Reversed After A 181% Six-Month Sprint - Dec 18th, 2025 2:15 pm
These Stocks Moved the Most Today: Micron, DJT, Accenture, Tilray, Lululemon, Medline, Rivian, and More - Dec 18th, 2025 2:13 pm
Insmed's Pipeline Can Deliver Potential Gains Despite Brensocatib Setback, RBC Says - Dec 18th, 2025 9:55 am
INSM Stock Plummets on Sinus Study Failure, Adds New Pipeline Asset - Dec 18th, 2025 5:59 am
Insmed Stock Plummets 19%. This Is What Sparked the Selloff. - Dec 18th, 2025 5:12 am